These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17926525)

  • 21. Outcomes of bleeding peptic ulcers: a prospective study.
    Liu NJ; Lee CS; Tang JH; Cheng HT; Chu YY; Sung KF; Lin CH; Tsou YK; Lien JM; Chen PC; Chiu CT; Cheng CL
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e340-7. PubMed ID: 17944885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The quality of care for Medicare patients with peptic ulcer disease.
    Ofman JJ; Etchason J; Alexander W; Stevens BR; Herrin J; Cangialose C; Ballard DJ; Bratzler D; Elward KS; FitzGerald D; Culpepper-Morgan J; Marshall B
    Am J Gastroenterol; 2000 Jan; 95(1):106-13. PubMed ID: 10638567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study of outcome after targeted intervention for peptic ulcer resistant to acid suppression therapy.
    Lanas A; Remacha B; Sáinz R; Hirschowitz BI
    Am J Gastroenterol; 2000 Feb; 95(2):513-9. PubMed ID: 10685760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rheumatologists' adherence to guidelines for misoprostol use in patients at high risk for nonsteroidal antiinflammatory drug gastropathy.
    Cibere J; Sibley JT; Haga M
    J Rheumatol; 2002 Feb; 29(2):339-46. PubMed ID: 11838854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endoscopic characteristics and Helicobacter pylori infection in NSAID-associated gastric ulcer.
    Kamada T; Hata J; Kusunoki H; Sugiu K; Tanimoto T; Mihara M; Hamada H; Kido S; Dongmei Q; Haruma K
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):98-102. PubMed ID: 16706819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Helicobacter pylori eradication may reduce the risk of gastroduodenal lesions in chronic NSAID users.
    Russell RI
    Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):465-9. PubMed ID: 9494858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.
    Arroyo MT; Forne M; de Argila CM; Feu F; Arenas J; de la Vega J; Garrigues V; Mora F; Castro M; Bujanda L; Cosme A; Castiella A; Gisbert JP; Hervas A; Lanas A
    Helicobacter; 2004 Jun; 9(3):249-54. PubMed ID: 15165261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of NSAIDs and infection with Helicobacter pylori--what does the rheumatologist need to know?
    Kiltz U; Zochling J; Schmidt WE; Braun J
    Rheumatology (Oxford); 2008 Sep; 47(9):1342-7. PubMed ID: 18477642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of acid suppressants in prophylaxis of NSAID damage.
    Chan FK; Sung JJ
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):433-45. PubMed ID: 11403537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Striking prevalence of over-the-counter nonsteroidal anti-inflammatory drug use in patients with upper gastrointestinal hemorrhage.
    Wilcox CM; Shalek KA; Cotsonis G
    Arch Intern Med; 1994 Jan; 154(1):42-6. PubMed ID: 8267488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Helicobacter pylori infection and development of gastric or duodenal ulcer in arthritic patients receiving chronic NSAID therapy. The Misoprostol Study Group.
    Kim JG; Graham DY
    Am J Gastroenterol; 1994 Feb; 89(2):203-7. PubMed ID: 8304304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complicated and uncomplicated peptic ulcers in a Danish county 1993-2002: a population-based cohort study.
    Lassen A; Hallas J; Schaffalitzky de Muckadell OB
    Am J Gastroenterol; 2006 May; 101(5):945-53. PubMed ID: 16573778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonsteroidal anti-inflammatory drugs, Helicobacter pylori, and ulcers: where we stand.
    Graham DY
    Am J Gastroenterol; 1996 Oct; 91(10):2080-6. PubMed ID: 8855725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-steroidal anti-inflammatory drugs (NSAID) cause gastrointestinal ulcers mainly in Helicobacter pylori carriers.
    Publig W; Wüstinger C; Zandl C
    Wien Klin Wochenschr; 1994; 106(9):276-9. PubMed ID: 8023522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Risk factors and comorbidities for NSAID associated ulcer].
    Kusunoki M; Miyake K; Sakamoto C
    Nihon Rinsho; 2007 Oct; 65(10):1781-7. PubMed ID: 17926524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Helicobacter pylori infection and NSAIDs on the risk of peptic ulcer bleeding.
    Mahachai V; Thomson AB; Vilaichone RK
    J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S295-9. PubMed ID: 16083206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of peptic ulcer related to rheumatic diseases].
    Imaeda H; Ishii H; Goto M
    Nihon Rinsho; 2002 Aug; 60(8):1585-91. PubMed ID: 12187755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms.
    Pilotto A; Seripa D; Franceschi M; Scarcelli C; Colaizzo D; Grandone E; Niro V; Andriulli A; Leandro G; Di Mario F; Dallapiccola B
    Gastroenterology; 2007 Aug; 133(2):465-71. PubMed ID: 17681167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of NSAID-induced ulcer disease.
    Clearfield HR
    Am Fam Physician; 1992 Jan; 45(1):255-8. PubMed ID: 1728095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.